FDAnews Drug Daily Bulletin

Elite Pharmaceuticals Announces FDA Approval of Supplemental Application for Naltrexone

Feb. 7, 2013
A A
Elite Pharmaceuticals announced on Jan. 31, 2012, the FDA approved the company’s supplemental application for the manufacturing and packaging of naltrexone hydrochloride 50 mg tablets.
Yahoo! Medical News